期刊
BIOCHEMISTRY
卷 55, 期 33, 页码 4636-4641出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.biochem.6b00565
关键词
-
资金
- National Institutes of Health [DA033760, DK909810]
- Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]
- National Cancer Institute Cancer Center Support Grant [P30 (CA014195)]
- Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals [DK098002]
- JPB foundation
- Hewitt Foundation
- Chapman Charitable Trust Fellowship
- UCSD Medical Scientist Training Program funding [T32 GM007198]
- Irving S. Sigal postdoctoral fellowship from the American Chemical Society
- Western Norway Regional Health Authority
- Novo Nordisk Foundation
- KG Jebsen Foundation
- [DK106210]
- Novo Nordisk Fonden [NNF14OC0010659, NNF15OC0016330] Funding Source: researchfish
A recently discovered class of endogenous mammalian lipids, branched fatty acid esters of hydroxy fatty acids (FAHFAs), possesses anti-diabetic and anti-inflammatory activities. Here, we identified and validated carboxyl ester lipase (CEL), a pancreatic enzyme hydrolyzing cholesteryl esters and other dietary lipids, as a FAHFA hydrolase. Variants of CEL have been linked to maturity-onset diabetes of the young, type 8 (MODY8), and to chronic pancreatitis. We tested the FAHFA hydrolysis activity of the CEL MODY8 variant and found a modest increase in activity as compared with that of the normal enzyme. Together, the data suggest that CEL might break down dietary FAHFAs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据